These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9681532)
1. Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Close DR; Kristal AR; Li S; Patterson RE; White E Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):627-30. PubMed ID: 9681532 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Agalliu I; Weiss NS; Lin DW; Stanford JL Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982 [TBL] [Abstract][Full Text] [Related]
3. Behavioral associations between prostate and colon cancer screening. Carlos RC; Underwood W; Fendrick AM; Bernstein SJ J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Bunker CH; Patrick AL; Konety BR; Dhir R; Brufsky AM; Vivas CA; Becich MJ; Trump DL; Kuller LH Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):726-9. PubMed ID: 12163325 [TBL] [Abstract][Full Text] [Related]
5. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Merrill RM Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662 [TBL] [Abstract][Full Text] [Related]
6. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334 [TBL] [Abstract][Full Text] [Related]
7. Self-reported prostate cancer screening in Austria. Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656 [TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK; J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007 [TBL] [Abstract][Full Text] [Related]
9. Digital rectal examination is barrier to population-based prostate cancer screening. Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431 [TBL] [Abstract][Full Text] [Related]
10. The value of prostatic specific antigen in prostate cancer screening in the community. Jubelirer SJ; Tierney JP; Oliver S; Serrato JM; Farra S; Plymale J; Hodge E W V Med J; 1994 Apr; 90(4):140-2. PubMed ID: 7516602 [TBL] [Abstract][Full Text] [Related]
11. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program. Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing use of the prostate-specific antigen screening test in primary care. Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069 [TBL] [Abstract][Full Text] [Related]
14. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium. Arch Intern Med; 1995 Feb; 155(4):389-92. PubMed ID: 7531426 [TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam. Beemsterboer PM; de Koning HJ; Kranse R; Trienekens PH; van der Maas PJ; Schröder FH J Urol; 2000 Oct; 164(4):1216-20. PubMed ID: 10992369 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997. McDavid K; Melnik TA; Derderian H Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632 [TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer: what do general practitioners think? Morris J; McNoe B N Z Med J; 1997 May; 110(1044):178-82. PubMed ID: 9201202 [TBL] [Abstract][Full Text] [Related]
18. Prostate carcinoma among men with human immunodeficiency virus infection. Crum NF; Spencer CR; Amling CL Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826 [TBL] [Abstract][Full Text] [Related]
19. Attitudes and practices of primary care physicians for prostate cancer screening. Hoffman RM; Papenfuss MR; Buller DB; Moon TE Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day). Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]